<h2>Question ❓:</h2>
what is the correct sequence ofa ctions for performing mouth to mouth and nose breaths for an infant
<h2>Answer ❄️: </h2>
blow a breath steadily into the babys mouth and nose over 1 second. It should be sufficient to make the chest visibly rise. Keeping their head tilted and chin lifted, take your mouth away and watch for the chest to fall as air comes out. Take another breath and repeat this sequence 4 more times.
Superficial: means situated near the surface. Peripheral also means outward or near the surface. Vs. • Deep: is used to describe parts that are more internal
Answer: HDLs are antiatherogenic lipoproteins....
Explanation:
The anti-atherogenic effect of HDL occurs, above all, because of its properties to carry lipids, mainly cholesterol esters from peripheral tissues to the liver, which is known as reverse cholesterol transport(RCT). However, other protective actions of HDL, in addition to RCT, have been described in several experimental models and epidemiological studies. These actions include antioxidant protection, mediation of cholesterol efflux, inhibition of the expression of cell adhesion, leukocyte activation, regulation of blood coagulation and platelet activity.
Answer:
b) blastic red blood cell (RBC).
Explanation:
In excess of 340 blood group antigens have now been described that vary between individuals. Thus, any unit of blood that is nonautologous represents a significant dose of alloantigen. Most blood group antigens are proteins, which differ by a single amino acid between donors and recipients. Approximately 1 out of every 70 individuals are transfused each year (in the United States alone), which leads to antibody responses to red blood cell <u>(RBC) alloantigens</u> in some transfusion recipients. When alloantibodies are formed, in many cases, RBCs expressing the antigen in question can no longer be safely transfused. However, despite chronic transfusion, only 3% to 10% of recipients (in general) mount an alloantibody response. In some disease states, rates of alloimmunization are much higher (eg, sickle cell disease). For patients who become alloimmunized to multiple antigens, ongoing transfusion therapy becomes increasingly difficult or, in some cases, impossible. While alloantibodies are the ultimate immune effector of humoral alloimmunization, the cellular underpinnings of the immune system that lead to ultimate alloantibody production are complex, including antigen consumption, antigen processing, antigen presentation, T-cell biology.
1) fatty will be the answer for your question!